Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

AC Immune (ACIU) Assets Average (2016 - 2025)

AC Immune has reported Assets Average over the past 9 years, most recently at $203.8 million for Q4 2025.

  • Quarterly Assets Average fell 25.29% to $203.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $203.8 million through Dec 2025, down 25.29% year-over-year, with the annual reading at $228.3 million for FY2025, 2.79% down from the prior year.
  • Assets Average was $203.8 million for Q4 2025 at AC Immune, down from $222.1 million in the prior quarter.
  • Over five years, Assets Average peaked at $272.8 million in Q4 2024 and troughed at $226507.9 in Q3 2021.
  • The 5-year median for Assets Average is $203.3 million (2025), against an average of $190.1 million.
  • Year-over-year, Assets Average tumbled 99.92% in 2021 and then surged 99172.58% in 2022.
  • A 5-year view of Assets Average shows it stood at $141.9 million in 2021, then surged by 43.03% to $202.9 million in 2022, then dropped by 9.33% to $184.0 million in 2023, then surged by 48.24% to $272.8 million in 2024, then dropped by 25.29% to $203.8 million in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Assets Average are $203.8 million (Q4 2025), $222.1 million (Q3 2025), and $232.3 million (Q2 2025).